Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation?

Pokorny, Herwig; Gnant, Michael; Rasoul-Rockenschaub, Susanne; Gollackner, Bernd; Steiner, Birgit; Steger, Günter; Steininger, Rudolf; Mühlbacher, Ferdinand

Pokorny, Herwig; Gnant, Michael; Rasoul-Rockenschaub, Susanne; Gollackner, Bernd; Steiner, Birgit; Steger, Günter; Steininger, Rudolf; Mühlbacher, Ferdinand.

Affiliation

Pokorny H; University Hospital of Vienna, Department of Transplant Surgery, Vienna, Austria. herwig.pokorny@meduniwien.ac.at

Am J Transplant ; 5(4 Pt 1): 788-94, 2005 Apr.

Article in En | MEDLINE | ID: mdl-15760403

Subject(s)

Antibiotics, Antineoplastic/pharmacology; Carcinoma, Hepatocellular/drug therapy; Doxorubicin/pharmacology; Liver Transplantation; Carcinoma, Hepatocellular/mortality; Carcinoma, Hepatocellular/surgery; Female; Humans; Male; Middle Aged; Risk Factors; Survival; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Liver Transplantation / Carcinoma, Hepatocellular / Antibiotics, Antineoplastic Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Am J Transplant Journal subject: TRANSPLANTE Year: 2005 Document type: Article Affiliation country: Austria

Search on Google

Add to My VHL

XML

PubMed Links